Platelet transfusion for neonates with thrombocytopaenia: protocol for a systematic review

• Published in: BMJ open 2020-10, Vol.10 (10), p.e039132-e039132
• Main Authors: Liu, Dengjun, Wu, Jinlin, Xiong, Tao, Yue, Yan, Tang, Jun
• Format: Article
• Language: English
• Subjects: Bias; bleeding disorders & coagulopathies; blood bank & transfusion medicine; Blood platelets; Case-Control Studies; Collaboration; Handbooks; Hospital Mortality; Humans; Infant, Newborn; Meta-Analysis as Topic; Morbidity; Mortality; neonatal intensive & critical care; Newborn babies; Paediatrics; Platelet Transfusion; Research Design; Sepsis; Software; Systematic review; Thrombocytopenia - therapy
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2020-039132

IntroductionThrombocytopaenia is one of the most common haemostatic abnormalities among neonates. It affects approximately one-quarter of neonates admitted into neonatal intensive care units and may lead to a high risk of bleeding and mortality, which are substantial causes for concern by neonatologists. Platelet transfusion (PT) is a specific treatment for thrombocytopaenia. To date, PT thresholds are diverse since the associations between low platelet count and negative outcomes are not clear. We propose this protocol for a systematic review to collect and assess evidence concerning the best PT threshold to reduce mortality, bleeding and major morbidity among neonates with thrombocytopaenia.Methods and analysisThe systematic review will be performed according to the Cochrane Handbook for Systematic Review of Interventions, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, and the Grading of Recommendations Assessment, Development and Evaluation system. Two independent researchers will perform the study selection, data extraction/coding, quality assessment and further analyses of the included studies, with disagreements being resolved by a third researcher. A systematic search of the literature will be conducted in the PubMed, Cochrane Library and Embase databases from database inception through 13 October 2020. All randomised controlled trials, cohort studies and case–control studies will be included without any restrictions regarding publication date or language. The primary outcomes will comprise in-hospital mortality and bleeding episodes. Endnote X9 and Review Manager V.5.3 software will be used to manage the selection process and statistical analysis, respectively. If the included studies are sufficient and homogeneous for any of the outcomes, a quantitative synthesis (meta-analysis) may be performed. Otherwise, we will conduct a narrative systematic review of the results.Ethics and disseminationEthical approval is not required for this study because the data will be obtained from published studies and will not include individual patient data. The results of this study are anticipated to be published in a peer-reviewed journal.PROSPERO registration numberCRD42020169262.